GRACELL BIOTECHNOLOGIES INC's ticker is GRCL and the CUSIP is 38406L103. A total of 46 filers reported holding GRACELL BIOTECHNOLOGIES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,752,000 | – | 3,038,889 | – | 1.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 7,884,870 | $109,363,000 | 1.20% |
| FRAZIER MANAGEMENT LLC | 851,638 | $11,812,000 | 0.94% |
| Vivo Capital, LLC | 961,359 | $13,334,000 | 0.60% |
| Temasek Holdings (Private) Ltd | 9,901,940 | $137,340,000 | 0.48% |
| CloudAlpha Capital Management Limited/Hong Kong | 75,000 | $1,040,000 | 0.31% |
| Capital International Sarl | 159,491 | $2,212,000 | 0.20% |
| Capital International, Inc./CA/ | 1,160,891 | $16,102,000 | 0.16% |
| Virtus ETF Advisers LLC | 14,608 | $203,000 | 0.09% |
| AlphaCentric Advisors LLC | 17,000 | $236,000 | 0.06% |
| VIKING GLOBAL INVESTORS LP | 1,357,859 | $18,834,000 | 0.05% |